1-4 of 4
Mariella D’Adda
Close
Sort by
Journal Articles

Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial

Clinical Trials & Observations
Maria Gabriella Mazzucconi, Francesco Rodeghiero, Giuseppe Avvisati, Valerio De Stefano, Luigi Gugliotta, Marco Ruggeri, Nicola Vianelli, Paola Fazi, Francesca Paoloni, Valeria Sargentini, Erminia Baldacci, Antonietta Ferretti, Bruno Martino, Iolanda Donatella Vincelli, Giuseppe Carli, Stefania Fortuna, Mauro Di Ianni, Paola Ranalli, Francesca Palandri, Nicola Polverelli, Elisabetta Lugli, Elena Rivolti, Andrea Patriarca, Angela Rago, Mariella D’Adda, Massimo Gentile, Sergio Siragusa, Silvia Sibilla, Angelo Michele Carella, Elena Rossi, Roberta Battistini, Francesco Zaja, Monica Bocchia, Nicola Di Renzo, Pellegrino Musto, Monica Crugnola, Anna Chiara Giuffrida, Mauro Krampera, Agostino Tafuri, Cristina Santoro
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1529–1540.
https://doi.org/10.1182/bloodadvances.2023010975
Published: 2024
Journal Articles

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

Clinical Trials & Observations
Margherita Maffioli, Barbara Mora, Somedeb Ball, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Nicola Polverelli, Elisa Rumi, Marianna Caramella, Maria Cristina Carraro, Mariella D’Adda, Alfredo Molteni, Cinzia Sissa, Francesca Lunghi, Alessandro Vismara, Marta Ubezio, Anna Guidetti, Sabrina Caberlon, Michela Anghilieri, Rami Komrokji, Daniele Cattaneo, Matteo Giovanni Della Porta, Toni Giorgino, Lorenza Bertù, Marco Brociner, Andrew Kuykendall, Francesco Passamonti
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1855–1864.
https://doi.org/10.1182/bloodadvances.2021006889
Published: 2022
Includes: Supplemental data
Journal Articles

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP

Clinical Trials & Observations
Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso, Francesco Albano, Mario Annunziata, Sara Barulli, Germana Beltrami, Micaela Bergamaschi, Gianni Binotto, Monica Bocchia, Giovanni Caocci, Isabella Capodanno, Francesco Cavazzini, Michele Cedrone, Marco Cerrano, Monica Crugnola, Mariella D’Adda, Chiara Elena, Carmen Fava, Paola Fazi, Claudio Fozza, Sara Galimberti, Valentina Giai, Antonella Gozzini, Gabriele Gugliotta, Alessandra Iurlo, Gaetano La Barba, Luciano Levato, Alessandro Lucchesi, Luigia Luciano, Francesca Lunghi, Monia Lunghi, Michele Malagola, Roberto Marasca, Bruno Martino, Angela Melpignano, Maria Cristina Miggiano, Enrico Montefusco, Caterina Musolino, Fausto Palmieri, Patrizia Pregno, Davide Rapezzi, Giovanna Rege-Cambrin, Serena Rupoli, Marzia Salvucci, Rosaria Sancetta, Simona Sica, Raffaele Spadano, Fabio Stagno, Mario Tiribelli, Simona Tomassetti, Elena Trabacchi, Massimiliano Bonifacio, Massimo Breccia, Fausto Castagnetti, Fabrizio Pane, Domenico Russo, Giuseppe Saglio, Simona Soverini, Paolo Vigneri, Gianantonio Rosti
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4280–4290.
https://doi.org/10.1182/bloodadvances.2019000865
Published: 2019
Journal Articles

Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients

Clinical Trials & Observations
Margherita Maffioli, Toni Giorgino, Barbara Mora, Alessandra Iurlo, Elena Elli, Maria Chiara Finazzi, Marianna Caramella, Elisa Rumi, Maria Cristina Carraro, Nicola Polverelli, Mariella D’Adda, Simona Malato, Marianna Rossi, Alfredo Molteni, Alessandro Vismara, Cinzia Sissa, Francesco Spina, Michela Anghilieri, Daniele Cattaneo, Rossella Renso, Marta Bellini, Maria Luisa Pioltelli, Chiara Cavalloni, Daniela Barraco, Raffaella Accetta, Lorenza Bertù, Matteo Giovanni Della Porta, Francesco Passamonti
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3196–3200.
https://doi.org/10.1182/bloodadvances.2019000646
Published: 2019
Includes: Supplemental data